ReviewEpigenetics & chromatin2025
DNA methylation reshapes the expression of adipokines and adipose factors in white adipose tissues.
Review in Epigenetics & chromatin, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Nutrient-Sensitive Epigenetic Modifiers as Candidate Biomarkers of Metabolic Dysfunction in Obesity: A Nutrigenomic Review.International journal of molecular sciences · 2026Review
- Association of Adiponectin Gene Polymorphism rs266729 in Obese People with Type Two Diabetes Mellitus in North Bulgaria's Population.International journal of molecular sciences · 2026Article
- Deciphering skeletal muscle development: cellular heterogeneity and molecular regulatory networks from single-cell and spatial transcriptomic perspectives.Frontiers in cell and developmental biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
The expansion of adipose tissue during obesity results in alterations in the expression of adipose-derived hormones or factors, which control whole-body energy metabolism. Epigenetics refers to the heritable modifications in gene function that arise without changes in DNA sequence and are sculped by environmental factors, lifestyles, and nutritional variables. DNA methylation is a well-characterized epigenetic mechanism, and altered expression of adipose-derived hormones or factors is partly ascribed to alterations in DNA methylation levels or patterns. This review aims to summarize the regulatory effects of DNA methylation on the expression of adipokines and adipose factors, including leptin, adiponectin, cytokines as well as insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) under obese conditions. The feasibility of DNA methylation as a biomarker for the prediction and prognosis of obesity and type 2 diabetes (T2D) would be also discussed.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.